Sulfonylureas: A New Look at Old Therapy
1
Section Endocrinology and Metabolism, Atlanta VA Medical Center, Atlanta, USA
|
Publication type: Journal Article
Publication date: 2014-02-22
scimago Q1
wos Q1
SJR: 2.163
CiteScore: 12.0
Impact factor: 6.4
ISSN: 15344827, 15390829
PubMed ID:
24563333
Endocrinology, Diabetes and Metabolism
Internal Medicine
Abstract
Sulfonylurea compounds were the first available oral antidiabetic agents and they remain an important tool in our quest for optimal glucose control. The sulfonylureas stimulate the release of insulin from pancreatic β-cells and have a number of extrapancreatic effects, including decreasing hepatic insulin clearance and reducing glucagon secretion in patients with type 2 diabetes. Although these agents have been the mainstay of pharmacotherapy for patients with type 2 diabetes mellitus (T2DM), their safety and clinical utility has been a matter of active debate in recent years, as their use is associated with risks of hypoglycemia and weight gain. We review the discovery and mechanisms of action of sulfonylureas, and the results of clinical trials to provide practical information on the pros and cons of their use in clinical practice. This review addresses advances in our understanding of mechanisms of action of sulfonylurea agents, their efficacy in T2DM, side effects, and impact on cardiovascular disease outcomes.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Diabetes Research and Clinical Practice
5 publications, 3.88%
|
|
|
Diabetes, Obesity and Metabolism
5 publications, 3.88%
|
|
|
Expert Opinion on Pharmacotherapy
3 publications, 2.33%
|
|
|
Frontiers in Endocrinology
2 publications, 1.55%
|
|
|
Foods
2 publications, 1.55%
|
|
|
Diabetes Therapy
2 publications, 1.55%
|
|
|
Diabetology and Metabolic Syndrome
2 publications, 1.55%
|
|
|
Endocrine Practice
2 publications, 1.55%
|
|
|
PLoS ONE
2 publications, 1.55%
|
|
|
Biomedicine and Pharmacotherapy
2 publications, 1.55%
|
|
|
Journal of Cellular Physiology
2 publications, 1.55%
|
|
|
Pharmaceutical Nanotechnology
1 publication, 0.78%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 0.78%
|
|
|
Reproduction
1 publication, 0.78%
|
|
|
Mediterranean Journal of Nutrition and Metabolism
1 publication, 0.78%
|
|
|
Biochemical Society Transactions
1 publication, 0.78%
|
|
|
Pediatric Emergency Care
1 publication, 0.78%
|
|
|
World Journal of Diabetes
1 publication, 0.78%
|
|
|
Journal of Aging and Health
1 publication, 0.78%
|
|
|
Applied Sciences (Switzerland)
1 publication, 0.78%
|
|
|
Frontiers in Neuroscience
1 publication, 0.78%
|
|
|
Frontiers in Pharmacology
1 publication, 0.78%
|
|
|
Frontiers in Cellular Neuroscience
1 publication, 0.78%
|
|
|
Nutrients
1 publication, 0.78%
|
|
|
Healthcare
1 publication, 0.78%
|
|
|
Journal of Diabetes and Metabolic Disorders
1 publication, 0.78%
|
|
|
Pharmacogenomics Journal
1 publication, 0.78%
|
|
|
Archives of Pharmacal Research
1 publication, 0.78%
|
|
|
Current Diabetes Reports
1 publication, 0.78%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Elsevier
33 publications, 25.58%
|
|
|
Springer Nature
22 publications, 17.05%
|
|
|
Wiley
19 publications, 14.73%
|
|
|
MDPI
8 publications, 6.2%
|
|
|
Taylor & Francis
8 publications, 6.2%
|
|
|
Frontiers Media S.A.
6 publications, 4.65%
|
|
|
Hindawi Limited
3 publications, 2.33%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 1.55%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.55%
|
|
|
American Association of Clinical Endocrinology
2 publications, 1.55%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.55%
|
|
|
Bioscientifica
1 publication, 0.78%
|
|
|
IOS Press
1 publication, 0.78%
|
|
|
Portland Press
1 publication, 0.78%
|
|
|
Baishideng Publishing Group
1 publication, 0.78%
|
|
|
SAGE
1 publication, 0.78%
|
|
|
Pharmaceutical Society of Korea
1 publication, 0.78%
|
|
|
King Saud University
1 publication, 0.78%
|
|
|
Shenyang Pharmaceutical University
1 publication, 0.78%
|
|
|
American Chemical Society (ACS)
1 publication, 0.78%
|
|
|
Oxford University Press
1 publication, 0.78%
|
|
|
BMJ
1 publication, 0.78%
|
|
|
American Society for Microbiology
1 publication, 0.78%
|
|
|
Edizioni Minerva Medica
1 publication, 0.78%
|
|
|
American Diabetes Association
1 publication, 0.78%
|
|
|
Touch Medical Media LTD.
1 publication, 0.78%
|
|
|
IntechOpen
1 publication, 0.78%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.78%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.78%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
129
Total citations:
129
Citations from 2024:
18
(13.95%)
Cite this
GOST |
RIS |
BibTex
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s11892-014-0473-5
UR - https://doi.org/10.1007/s11892-014-0473-5
TI - Sulfonylureas: A New Look at Old Therapy
T2 - Current Diabetes Reports
AU - Thulé, Peter M.
AU - Umpierrez, Guillermo
PY - 2014
DA - 2014/02/22
PB - Springer Nature
IS - 4
VL - 14
PMID - 24563333
SN - 1534-4827
SN - 1539-0829
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2014_Thulé,
author = {Peter M. Thulé and Guillermo Umpierrez},
title = {Sulfonylureas: A New Look at Old Therapy},
journal = {Current Diabetes Reports},
year = {2014},
volume = {14},
publisher = {Springer Nature},
month = {feb},
url = {https://doi.org/10.1007/s11892-014-0473-5},
number = {4},
pages = {473},
doi = {10.1007/s11892-014-0473-5}
}